View up-to-date information on Alembic Pharmaceuticals Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220211725A1 | Application | Pharmaceutical Composition Comprising Venetoclax | A61K31/635; A61K9/2009; A61K9/2018; A61K9/2027; A61K9/2095 | July 07, 2022 |
| US20220175774A1 | Application | Bioavailable Oral Dosage Form Of Tyrosine-Kinase Inhibitor | A61K31/506; A61K9/1694; A61K9/2013; A61K9/2018; A61K9/2054; A61K9/2095; A61K9/284; A61K9/2893 | June 09, 2022 |
| WO2022104150A1 | Application | TRIPLE COMBINATION TO TREAT B-CELL MALIGNANCIES | A61K31/5025; A61K31/5025; A61K31/519; A61K31/519; A61K39/3955; A61K39/39558; A61K45/06; A61K45/06; A61P35/00; A61P35/00; A61P35/02; C07K16/2887; C07K16/2887; C07K2317/24 | May 19, 2022 |
| EP2916868B1 | Grant | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT EINEM PDE4-HEMMER UND EINEM PI3-DELTA- ODER EINEM DUALEN PI3-DELTA-GAMMA-KINASEHEMMER | A61K2300/00; A61K31/353; A61K31/44; A61K31/47; A61K31/519; A61K31/52; A61K45/06; A61P1/04; A61P1/16; A61P11/00; A61P11/02; A61P11/06; A61P11/08; A61P13/10; A61P13/12; A61P15/02; A61P17/00; A61P17/04; A61P17/06; A61P19/02; A61P19/10; A61P21/00; A61P21/04; A61P25/00; A61P27/14; A61P29/00; A61P3/10; A61P37/02; A61P37/06; A61P37/08; A61P43/00; A61P7/06; A61P9/00 | May 11, 2022 |
| WO2022090953A1 | Application | A SOLID DISPERSION OF PONATINIB HYDROCHLORIDE AND PROCESS OF PREPARATION THEREOF | C07D487/04; Y02P20/54 | May 05, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward